TL
Tilray Brands, Inc.
TLRY · NASDAQ
$4.50 -0.22% (-$0.01)
1M +1.35%
Market Cap $506.6M
P/E Ratio -
Div. Yield -
ROE 7.95%
Piotroski F-Score Weak
3/9Valuation
44 /100
Fair P/B 0.31x
EV/EBITDA 41.88x
P/S 0.44x
Growth
26 /100
Declining Book val. growth 28.77%
Rev. growth 2.72%
FCF growth N/A
Profitability
10 /100
Weak Op. margin 5.18%
Gross margin 27.57%
FCF margin 9.87%
Quality
6 /100
Poor ROA 6.40%
ROIC 3.46%
Asset turnover 0.50x
Debt
45 /100
Moderate Int. coverage -2.31x
Debt/Equity 0.25x
Net debt/EBITDA 10.63x
Stability
15 /100
Unstable EPS volatility 428.66%
Beta 1.91x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TLRY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
3,595
Headquarters
Leamington
Evenimente viitoare
08 OCT.
Earnings
Upcoming earnings report